![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/485 | (2006.01) |
A61K 47/14 | (2013.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 9/08 | (2013.01) | ||
A61K 47/14 | (2017.01) | ||
A61K 47/44 | (2013.01) | ||
A61K 47/44 | (2017.01) | ||
A61K 31/485 | (2013.01) | ||
A61P 25/04 | (2006.01) | ||
A61K 9/0019 | (2013.01) | ||
A61K 47/10 | (2013.01) | ||
A61P 25/04 | (2018.01) |
(11) | Patento numeris | 3302477 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16799432.6 |
Europos patento paraiškos padavimo data | 2016-05-27 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-07 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2016/000857 |
Data | 2016-05-27 |
(87) | Numeris | WO 2016/189393 |
Data | 2016-12-01 |
(30) | Numeris | Data | Šalis |
201514723996 | 2015-05-28 | US | |
201562255805 P | 2015-11-16 | US |
(72) |
LI, Chan-Jung , TW
CHOU, David, Chih-Kuang , US
HUANG, Jin-Ding , TW
TSAI, Shin, Jr. , TW
KUO, Shu-Wen , TW
TIEN, Yu-En , TW
|
(73) |
Lumosa Therapeutics Co., Ltd. ,
4F
No. 3-2 Park Street
Nangang District, Taipei 11503,
TW
Shanghai Lumosa Therapeutics Co., Ltd. , Room 3026, 3rd Floor, Building 1 No. 146, 1st East Fute Road Shanghai Pilot Free Trade Zone, Shanghai 200131, CN |
(54) | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER |
PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER |